Nova Eye Medical (EYE) Discussion, page-53

All good mate, myself and others have posted quite a bit of analysis at the top of this thread so feel free to give it a read. The investor presentations are also quite informative.

It's pretty tough to get your head around it all at first given it is focused on ophthalmology (and surgery!) which is a complex field. Once you get your head around all the medical terms and the general anatomy of they eye (and the various ways in which different ophthalmic conditions can effect it) you begin to understand the massive potential of this company to really dominate both in MIGS for glaucoma as well as potentially even intermediate AMD (a few years away though). Given the size of both these markets (and the fact that the latter is an unmet disease) the revenue potential is massive and are both therefore very exciting opportunities